Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Clinical Follow-up Study With Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Subjects

NCT05705973 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT05705973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05705973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Clinical Follow-up Study With Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Subjects
Lead sponsor
Terumo Europe N.V.
Phase
Observational
Overall status
Active, not recruiting
Start date
April 25, 2023
Completion date
April 29, 2027
Enrollment
3,000 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary artery occlusion, ischemic heart disease